Impact BiomedicalIBO
13F holders, Q3 2024 (September 30)9holders
$2.00avg. 13F price*
At the end of Q3 2024, 9 institutions reported holding Impact Biomedical Inc. (IBO) in their 13F filings. The largest holders were Jane Street Group, LLC ($27K), HRT Financial LP ($25K) and Bank of America Corp. ($5K).
- Company
- Impact Biomedical Inc.
- CUSIP
- 45259L205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $59K |
| Exits | 0 | $0 |
Ownership 9 holders
| Jane Street Group, LLC | 0.00% | New | 13,361 | $27K |
| HRT Financial LP | 0.00% | New | 12,502 | $25K |
| Bank of America Corp. | 0.00% | New | 2,596 | $5K |
| Barclays PLC | 0.00% | New | 1,120 | $2K |
| Morgan Stanley | 0.00% | New | 58 | $116 |
| Wells Fargo & Company | 0.00% | New | 29 | $58 |
| Danske Bank A/S | 0.00% | New | 3 | $6 |
| UBS Group AG | 0.00% | New | 3 | $6 |
| Group One Trading LLC | 0.00% | New | 1 | $2 |
"% of holder's portfolio" is IBO's weight in each manager's 13F, not the share of Impact Biomedical Inc. the manager owns.